Drug class
Ergot-derived alpha-1 adrenergic receptor antagonist; peripheral and cerebral vasodilator
Mechanism of action
Antagonises alpha-1 adrenergic receptors on vascular smooth muscle, reducing catecholamine-mediated vasoconstriction and increasing blood flow. It also has effects on cerebral metabolism and platelet aggregation described in pharmacology studies.
General use cases
- Historically used in selected countries for peripheral vascular disorders and cognitive symptoms associated with cerebrovascular disease; current indications and availability are restricted or vary by jurisdiction.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
